Anti-myelin antibodies do not allow earlier diagnosis of multiple sclerosis

被引：60

作者：

Lim, ET

Berger, T

Reindl, M

Dalton, CM

Fernando, K

Keir, G

Thompson, EJ

Miller, DH

Giovannoni, G

机构：

[1] UCL, Inst Neurol, Dept Neuroinflammat, MS NMR Res Unit, London WC1N 3BG, England

[2] Innsbruck Med Univ, Dept Clin Neurol, A-6020 Innsbruck, Austria

来源：

MULTIPLE SCLEROSIS JOURNAL | 2005年 / 11卷 / 04期

关键词：

anti-myelin antibodies; clinically isolated syndrome; multiple sclerosis;

D O I：

10.1191/1352458505ms1187sr

中图分类号：

R74 [神经病学与精神病学];

学科分类号：

摘要：

This study investigates whether the presence of serum and plasma anti-myelin oligodendrocyte glycoprotein (MOG) and anti-myelin basic protein (MBP) in patients presenting with a clinically isolated syndrome compatible with demyelination (CIS) predicts early conversion to multiple sclerosis (MS). Forty-seven patients with CIS (46 with optic neuritis) had anti-MOG and anti-MBP antibodies analysed at baseline, and clinical and magnetic resonance imaging assessments. There was no evidence that the MS status based on either the McDonald or Poser criteria relates to the antibody status.

引用

页码：492 / 494

页数：3

共 50 条

[1] Anti-myelin oligodendrocyte glycoprotein antibodies in multiple sclerosis
Reder, AT
Oger, JJ
[J]. NEUROLOGY, 2004, 62 (11) : 1922 - 1923
[2] Anti-myelin antibodies in multiple sclerosis: clinically useful?
Polman, CH
Killestein, J
[J]. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 2006, 77 (06): : 712 - 712
[3] Influence of immunomodulatory therapies on anti-myelin antibodies in multiple sclerosis
Khalil, M
Reindl, M
Egg, R
Lutterotti, A
Ehling, R
Gneiss, C
Deisenhammer, E
Berger, T
[J]. MULTIPLE SCLEROSIS JOURNAL, 2004, 10 : S211 - S212
[4] Anti-myelin antibodies modulate clinical expression of childhood multiple sclerosis
O'Connor, K. C.
Lopez-Amaya, C.
Gagne, D.
Lovato, L.
Moore-Odom, N. H.
Kennedy, J.
Krupp, L.
Tenembaum, S.
Ness, J.
Belman, A.
Boyko, A.
Bykova, O.
Mah, J. K.
Stoian, C. A.
Waubant, E.
Kremenchutzky, M.
Ruggieri, M.
Bardini, M. R.
Rensel, M.
Hahn, J.
Weinstock-Guttman, B.
Yeh, E. A.
Farrell, K.
Freedman, M. S.
Iivanainen, M.
Bhan, V.
Dilenge, M.
Hancock, M. A.
Gano, D.
Fattahie, R.
Kopel, L.
Fournier, A. E.
Moscarello, M.
Banwell, B.
Bar-Or, A.
[J]. JOURNAL OF NEUROIMMUNOLOGY, 2010, 223 (1-2) : 92 - 99
[5] Anti-myelin antibodies (Abs) in pediatric multiple sclerosis: A window into initiating targets
Bar-Or, A
Lopez-Amaya, C
O'Connor, K
Fournier, A
Banwell, B
Moscarello, M
Krupp, L
Kopel, L
Fattahie, R
Moore, N
Gano, D
[J]. FASEB JOURNAL, 2005, 19 (05): : A1440 - A1441
[6] Enhanced levels of anti-myelin antibodies in multiple sclerosis patients as assessed by flow cytometry
Breij, E. C. W.
Heijnen, D. A. M.
van der Goes, A.
Teunissen, C. E.
Polman, C. H.
Dijkstra, C. D.
[J]. JOURNAL OF NEUROIMMUNOLOGY, 2006, 178 : 196 - 196
[7] Anti-Myelin Oligoglycoprotein (MOG) Positivity In Multiple Sclerosis
Manser, M.
Tierney, C.
Dave, R. H.
[J]. MULTIPLE SCLEROSIS JOURNAL, 2020, 26 (1_SUPPL) : 56 - 56
[8] Cerebrospinal fluid anti-myelin antibodies are related to MRI lesion numbers in multiple sclerosis
Vogt, M. H. J.
Teunissen, C. E.
Iacobaeus, E.
Heijnen, D. A. M.
Breij, E. C. W.
Olsson, T.
Brandin, L.
Killestein, J.
Dijkstra, C. D.
[J]. MULTIPLE SCLEROSIS, 2007, 13 : S39 - S39
[9] Prognostic value of serum anti-myelin antibodies in early multiple sclerosis as measured by a myelin flow cytometry assay
Nielsen, J. M.
Breij, EC. W.
Polman, C. H.
Heijnen, D. A. M.
Korteweg, T.
Vloet, R.
van Winsen, L.
Uitdehaag, B. M. J.
Barkhof, F.
Dijkstro, C. D.
[J]. MULTIPLE SCLEROSIS, 2006, 12 : S66 - S66
[10] Anti-myelin antibodies in clinically isolated syndrome indicate the risk of multiple sclerosis in a Swiss cohort
Greeve, I.
Sellener, J.
Lauterburg, T.
Walker, U.
Roesler, K. M.
Mattle, H. P.
[J]. ACTA NEUROLOGICA SCANDINAVICA, 2007, 116 (04): : 207 - 210

← 1 2 3 4 5 →